1. Home
  2. AMG vs CYTK Comparison

AMG vs CYTK Comparison

Compare AMG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMG
  • CYTK
  • Stock Information
  • Founded
  • AMG 1993
  • CYTK 1997
  • Country
  • AMG United States
  • CYTK United States
  • Employees
  • AMG N/A
  • CYTK N/A
  • Industry
  • AMG Investment Managers
  • CYTK Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMG Finance
  • CYTK Health Care
  • Exchange
  • AMG Nasdaq
  • CYTK Nasdaq
  • Market Cap
  • AMG 4.7B
  • CYTK 5.6B
  • IPO Year
  • AMG 1997
  • CYTK 2004
  • Fundamental
  • Price
  • AMG $180.68
  • CYTK $29.84
  • Analyst Decision
  • AMG Buy
  • CYTK Buy
  • Analyst Count
  • AMG 5
  • CYTK 18
  • Target Price
  • AMG $199.40
  • CYTK $75.65
  • AVG Volume (30 Days)
  • AMG 238.1K
  • CYTK 2.2M
  • Earning Date
  • AMG 05-08-2025
  • CYTK 05-06-2025
  • Dividend Yield
  • AMG 0.02%
  • CYTK N/A
  • EPS Growth
  • AMG N/A
  • CYTK N/A
  • EPS
  • AMG 13.18
  • CYTK N/A
  • Revenue
  • AMG $2,037,600,000.00
  • CYTK $19,218,000.00
  • Revenue This Year
  • AMG $3.19
  • CYTK $50.43
  • Revenue Next Year
  • AMG $4.51
  • CYTK $589.25
  • P/E Ratio
  • AMG $13.73
  • CYTK N/A
  • Revenue Growth
  • AMG N/A
  • CYTK 412.21
  • 52 Week Low
  • AMG $139.22
  • CYTK $31.67
  • 52 Week High
  • AMG $199.52
  • CYTK $68.44
  • Technical
  • Relative Strength Index (RSI)
  • AMG 64.42
  • CYTK 27.46
  • Support Level
  • AMG $170.27
  • CYTK $31.67
  • Resistance Level
  • AMG $188.62
  • CYTK $33.37
  • Average True Range (ATR)
  • AMG 5.12
  • CYTK 1.85
  • MACD
  • AMG 1.50
  • CYTK -0.77
  • Stochastic Oscillator
  • AMG 71.92
  • CYTK 3.73

About AMG Affiliated Managers Group Inc.

Affiliated Managers Group offers investment strategies to investors through its network of affiliates. The firm typically buys a majority interest in small to midsize boutique asset managers, receiving a fixed percentage of revenue from these firms in return. Affiliates operate independently, with AMG providing strategic, operational, and technology support, as well as global distribution. At the end of September 2024, AMG's affiliate network-which includes firms like AQR Capital Management, and Pantheon in alternative assets and other products (which accounted for 36% of AUM), Artemis, Genesis, Harding Loevner, and Tweedy Browne in global and emerging-market equities (27%) and Frontier, River Road, Parnassus, and Yacktman in US equities (21%)-had $728.4 billion in managed assets.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: